Shots:
- The US FDA has granted conditional approval to Elanco’s Credelio Quattro-CA1 (lotilaner, moxidectin, praziquantel, & pyrantel) for the treatment of infestations caused by New World screwworm larvae (myiasis) in dogs
- Approval was based on a study showing that oral lotilaner achieved 100% efficacy against New World screwworm (Cochliomyia hominivorax) larvae within 24hrs. at the minimum recommended dose in naturally infested dogs; data published in Parasites & Vectors
- Credelio Quattro-CA1 is a monthly chewable tablet that kills 7 types of parasites, incl. ticks, fleas, New World screwworm & heartworm disease, as well as 3 types of intestinal parasites: roundworms, hookworms, & tapeworms
Ref: PR Newswire| Image: Elanco |Press Release
Related News: Elanco’s Credelio CAT (Lotilaner) Receives the US FDA’s EUA Against New World Screwworm in Cats
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
